Andreas Pircher
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Angiogenesis and VEGF in Cancer 18
- Single-cell and spatial transcriptomics 7
- Oncology 36
- Cancer Immunotherapy and Biomarkers 18
- Lung Cancer Research Studies 7
- Co-authors
- Dominik Wolf (34 shared papers)Peter Carmeliet (7 shared papers)Bernard Thienpont (2 shared papers)Isabel Heidegger (28 shared papers)Lena Horvath (8 shared papers)Wolfgang Hilbe (23 shared papers)Renate Pichler (12 shared papers)Sara Aibar (1 shared paper)
- Journals
- Lung Cancer (9 papers)Molecular Cancer (3 papers)European Urology Oncology (3 papers)PLoS ONE (3 papers)Translational Lung Cancer Research (3 papers)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Andreas Pircher
103 papers receiving 3.5k citations
Andreas Pircher's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 787
- Oncology 1.3k
- Immunology 797
- Pulmonary and Respiratory Medicine 663
- Molecular Biology 1.5k
Countries citing papers authored by Andreas Pircher
This map shows the geographic impact of Andreas Pircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Pircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Pircher more than expected).
Fields of papers citing papers by Andreas Pircher
This network shows the impact of papers produced by Andreas Pircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Pircher. The network helps show where Andreas Pircher may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Pircher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phenotype molding of stromal cells in the lung tumor microenvironment Hit paper breakdown → | 2018 | 1086 |
| 2 | 2020 | 195 | |
| 3 | 2020 | 138 | |
| 4 | 2015 | 127 | |
| 5 | 2014 | 127 | |
| 6 | 2019 | 96 | |
| 7 | 2016 | 86 | |
| 8 | 2011 | 71 | |
| 9 | 2016 | 70 | |
| 10 | 2019 | 70 | |
| 11 | 2011 | 67 | |
| 12 | 2017 | 67 | |
| 13 | 2014 | 64 | |
| 14 | 2018 | 62 | |
| 15 | 2017 | 54 | |
| 16 | 2014 | 51 | |
| 17 | 2014 | 45 | |
| 18 | 2021 | 45 | |
| 19 | 2017 | 45 | |
| 20 | 2021 | 43 |
About Andreas Pircher
Andreas Pircher is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 109 papers that have together received 3.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (18 papers), Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer, Hypoxia, and Metabolism (8 papers), Single-cell and spatial transcriptomics (7 papers), Prostate Cancer Treatment and Research (7 papers), Lung Cancer Research Studies (7 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Cancer Research (787 citations), Oncology (1.3k citations), Immunology (797 citations), Pulmonary and Respiratory Medicine (663 citations) and Molecular Biology (1.5k citations). Andreas Pircher has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Dominik Wolf, Peter Carmeliet, Bernard Thienpont, Isabel Heidegger, Lena Horvath, Wolfgang Hilbe, Renate Pichler, Sara Aibar, Johan Vansteenkiste and Oliver T. Burton. Their work appears in journals such as Lung Cancer, Molecular Cancer, European Urology Oncology, PLoS ONE and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.